There’s a huge difference in OGRMF Vs. ACB. ACB did not perform well because they have almost 1 Billion shares issued with a market cap of 8 billion and a history of over paying for companies with shares that dilute their worth because they’re over paying.
OGRMF takes a way different approach with way better fundamentals, 130 million shares issued and a billion market cap that makes it a gem at only 10 times current revenue. Some big MJ companies are trading 30 to 40 times revenue for their market cap. The NASDAQ will open OGRMF up to institutional investors which do not invest in the current OTC Market they reside in. Institutional Investors look at fundamentals which Organigram blows Aroura away on.
Also Organigram has the lowest production cost per gram by almost half the next best producer. Heck costs them less overall to produce flower than companies using greenhouses. Nothing is for sure but OGRMF checks many of the boxes I look for when investing. Oh and Tilray though it was an IPO went from $20 to over $200 when they entered the big boy club though at $50 now.
Market Data 
Markets 
AI
